Shane Andrew Tipton, PA
Physician Assistant · Sonora
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 22 years
- University of California, Davis School of Medicine, 2004
Offices
1 location · Sonora Community Hospital · 134 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health Sonora · Mark Twain Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Shane Andrew Tipton’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health SonoraSonora, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Postoperative wound dehiscence rate: 3.5 (2.04 to 4.96) · 288 cases, Jul 2022 – Jun 2024Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.6) · 1,004 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
- Mark Twain Medical CenterSan Andreas, CACritical Access Hospital · Voluntary non-profit - Other · No emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 73% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Adventist Health Sonora
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative wound dehiscence rateComplications and deaths | 3.5 (2.04 to 4.96) · 288 cases | Worse | Jul 2022 – Jun 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.6) · 1,004 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.15 (0.14 to 2.16) · 582 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.5 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 182.91 (123.44 to 242.37) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 236 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15 · 433 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,364 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.39) · 3,671 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,602 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.24 to 5.59) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.24) · 310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.98 to 4.2) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.97 (0 to 16.16) · 306 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.72 (1.85 to 9.58) · 277 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.06) · 2,750 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.614 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 105 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 209 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.6 · 119 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -23.8 · 255 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.4 · 455 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 381 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4.3 to 8.1) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (9.1 to 14.7) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.3) · 1,835 cases | No different | Jan 2022 – Dec 2024 |
What patients said (326 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Mark Twain Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 9.3 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.9 · 116 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 353 cases | None | Jul 2024 – Jun 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 81.9 · 54 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33.7 · 108 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4 to 9.3) · 54 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (7.3 to 14.2) · 54 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.4) · 375 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 89 cases | No different | Jan 2024 – Dec 2024 |
What patients said (151 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 89% |
| Nurses "always" communicated well | 90% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 85% |
| Nurses "always" listened carefully | 91% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 60% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$101,342
Medicare paid this office $101,342 for 685 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 319 | $45,164 | $63 |
| Short return visit (20+ min) | 413 | $26,380 | $41 |
| New patient visit (45+ min) | 89 | $7,513 | $84 |
| Telephone medical discussion with physician, 21-30 minutes | 80 | $7,179 | $61 |
| Telephone medical discussion with physician, 21-30 minutes | 71 | $5,342 | $64 |
See all 10 services
| Return visit (30+ min) | 319 | $45,164 | $63 |
| Short return visit (20+ min) | 413 | $26,380 | $41 |
| New patient visit (45+ min) | 89 | $7,513 | $84 |
| Telephone medical discussion with physician, 21-30 minutes | 80 | $7,179 | $61 |
| Telephone medical discussion with physician, 21-30 minutes | 71 | $5,342 | $64 |
| Long return visit (40+ min) | 24 | $2,706 | $97 |
| New patient visit (60+ min) | 21 | $2,543 | $121 |
| New patient visit (30+ min) | 41 | $2,033 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $1,017 | $27 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 13 | $650 | $50 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of bone marrow | – | – | 13 | 17 | 15 | – |
| Biopsy and aspiration of bone marrow sample for diagnosis | – | – | – | – | – | 13 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
685 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 15% · Women 57% · Also on Medicaid 18% · Health risk score 1.59. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 72% · Cancer 53% · Diabetes 26% · Coronary heart disease 23% · Chronic kidney disease 23% · COPD 22% · Depression 19% · Atrial fibrillation 16% · Heart failure 14% · Stroke 9% · Dementia 4%.
The office billed $317,405, Medicare allowed $133,654 and paid $101,342; for 1,810 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 685 | 1,810 | 75 | 1.59 | $317,405 | $101,342 |
| 2023 | 634 | 1,900 | 75 | 1.53 | $242,298 | $96,867 |
| 2022 | 569 | 1,710 | 75 | 1.47 | $230,863 | $90,950 |
| 2021 | 438 | 1,467 | 74 | 1.66 | $187,695 | $79,942 |
| 2020 | 376 | 1,215 | 74 | 1.83 | $153,996 | $56,434 |
| 2019 | 352 | 981 | 74 | 1.83 | $109,846 | $42,578 |
| 2018 | 166 | 455 | 74 | 1.84 | $48,806 | $18,722 |
| 2017 | 153 | 472 | 73 | 1.78 | $48,696 | $20,491 |
| 2016 | 153 | 244 | 74 | 2.13 | $30,465 | $13,213 |
| 2015 | 35 | 45 | 71 | 1.70 | $5,563 | $2,521 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Short return visit (20+ min) | 477 | $39,339 | $42 |
| Return visit (30+ min) | 200 | $32,100 | $65 |
| Telephone medical discussion with physician, 11-20 minutes | 132 | $7,236 | $39 |
| New patient visit (30+ min) | 122 | $6,529 | $54 |
| Telephone medical discussion with physician, 21-30 minutes | 48 | $4,863 | $67 |
| New patient visit (45+ min) | 44 | $4,000 | $91 |
| Biopsy of bone marrow | 15 | $723 | $48 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $548 | $42 |
2022: 7 services
| Return visit (30+ min) | 232 | $37,572 | $63 |
| Short return visit (20+ min) | 426 | $31,904 | $43 |
| New patient visit (45+ min) | 85 | $7,344 | $86 |
| Telephone medical discussion with physician, 11-20 minutes | 93 | $6,071 | $40 |
| New patient visit (30+ min) | 52 | $2,985 | $57 |
| Telephone medical discussion with physician, 21-30 minutes | 33 | $2,902 | $63 |
| Biopsy of bone marrow | 17 | $843 | $50 |
2021: 7 services
| Return visit (30+ min) | 208 | $36,284 | $66 |
| Short return visit (20+ min) | 332 | $29,118 | $43 |
| New patient visit (45+ min) | 54 | $4,744 | $88 |
| Telephone medical discussion with physician, 11-20 minutes | 59 | $4,105 | $45 |
| Long return visit (40+ min) | 18 | $1,857 | $103 |
| New patient visit (30+ min) | 17 | $878 | $52 |
| Biopsy of bone marrow | 13 | $595 | $46 |
2020: 5 services
| Return visit (30+ min) | 236 | $34,287 | $55 |
| Short return visit (20+ min) | 268 | $15,460 | $32 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,151 | $143 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $1,342 | $35 |
| New patient visit (45+ min) | 12 | $997 | $83 |
2019: 5 services
| Short return visit (20+ min) | 301 | $20,016 | $34 |
| Return visit (30+ min) | 144 | $16,031 | $54 |
| New patient visit (45+ min) | 25 | $2,151 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,111 | $141 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $71 | $6 |
2018: 5 services
| Short return visit (20+ min) | 104 | $5,820 | $31 |
| Return visit (30+ min) | 70 | $5,291 | $49 |
| Short return visit (20+ min) | 63 | $2,926 | $35 |
| Return visit (30+ min) | 25 | $1,783 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,147 | $72 |
2017: 5 services
| Short return visit (20+ min) | 116 | $8,714 | $34 |
| Return visit (30+ min) | 54 | $6,882 | $53 |
| New patient visit (45+ min) | 18 | $1,514 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,079 | $72 |
| New patient visit (30+ min) | 20 | $1,049 | $52 |
2016: 7 services
| Return visit (30+ min) | 42 | $3,299 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,092 | $139 |
| Short return visit (20+ min) | 47 | $1,831 | $35 |
| New patient visit (45+ min) | 14 | $1,251 | $89 |
| Short return visit (20+ min) | 29 | $915 | $32 |
| Return visit (30+ min) | 17 | $865 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $596 | $50 |
2015: 2 services
| Return visit (30+ min) | 12 | $615 | $51 |
| Short return visit (20+ min) | 14 | $491 | $35 |
Medicaid work
$173 in 2023
Medicaid paid $173 for 12 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 12 | $173 |
| 2023 | 12 | 1 | 12 | $173 |
| 2022 | 117 | 2 | 18 | $34 |
| 2021 | 89 | 1 | 17 | $0 |
| 2020 | 43 | 1 | 16 | $0 |
See the largest Medicaid services in earlier years
2022
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 26 | $34 |
| Hospital outpatient clinic visit for assessment and management of a patient | 91 | $0 |
2021
| Hospital outpatient clinic visit for assessment and management of a patient | 89 | $0 |
2020
| Hospital outpatient clinic visit for assessment and management of a patient | 43 | $0 |
Drugs they prescribed that Part D paid
$3,437,685
Pharmacies billed $3,437,685 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (260 of 2,075) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%. Long-acting opioids: 30% of their opioid prescriptions.
1,722 generic and fewer than 11 brand-name prescriptions · $3,437,685 in drug cost · 61 antibiotic prescriptions to 42 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Revlimid | 24 | $407,919 | $16,997 |
| Imbruvica | 33 | $334,464 | $10,135 |
| Xtandi | 21 | $283,073 | $13,480 |
| Inlyta | 13 | $255,518 | $19,655 |
| Venclexta | 35 | $86,118 | $2,461 |
See all 50 drugs
| Revlimid | 24 | $407,919 | $16,997 |
| Imbruvica | 33 | $334,464 | $10,135 |
| Xtandi | 21 | $283,073 | $13,480 |
| Inlyta | 13 | $255,518 | $19,655 |
| Venclexta | 35 | $86,118 | $2,461 |
| Abiraterone Acetate | 108 | $42,808 | $396 |
| Eliquis | 41 | $31,721 | $774 |
| Imatinib Mesylate | 20 | $11,512 | $576 |
| Xtampza Er | 13 | $7,018 | $540 |
| Fentanyl | 30 | $3,091 | $103 |
| Anastrozole | 105 | $2,626 | $25 |
| Oxycodone-Acetaminophen | 35 | $2,082 | $59 |
| Exemestane | 24 | $1,664 | $69 |
| Hydrocodone-Acetaminophen | 48 | $1,470 | $31 |
| Ondansetron | 86 | $1,094 | $13 |
| Bicalutamide | 19 | $854 | $45 |
| Letrozole | 43 | $812 | $19 |
| Morphine Sulfate Er | 32 | $781 | $24 |
| Hydroxyurea | 28 | $780 | $28 |
| Gabapentin | 57 | $759 | $13 |
| Prednisone | 122 | $734 | $6 |
| Oxycodone | 50 | $721 | $14 |
| Prochlorperazine Maleate | 48 | $646 | $13 |
| Zolpidem | 42 | $612 | $15 |
| Dexamethasone | 41 | $564 | $14 |
| Potassium Chloride | 39 | $533 | $14 |
| Levothyroxine | 38 | $458 | $12 |
| Albuterol Sulfate Hfa | 19 | $369 | $19 |
| Diphenoxylate-Atropine | 20 | $281 | $14 |
| Ondansetron Odt | 23 | $268 | $12 |
| Tamoxifen Citrate | 14 | $225 | $16 |
| Lidocaine-Prilocaine | 17 | $223 | $13 |
| Lorazepam | 30 | $206 | $7 |
| Morphine Sulfate | 13 | $195 | $15 |
| Allopurinol | 15 | $176 | $12 |
| Alprazolam | 26 | $165 | $6 |
| Famotidine | 13 | $161 | $12 |
| Tramadol | 23 | $134 | $6 |
| Methylprednisolone | 15 | $118 | $8 |
| Amlodipine Besylate | 17 | $117 | $7 |
| Acyclovir | 13 | $98 | $8 |
| Lidocaine Hcl Viscous | 13 | $92 | $7 |
| Escitalopram | 11 | $88 | $8 |
| Trazodone | 13 | $83 | $6 |
| Levofloxacin | 12 | $63 | $5 |
| Mirtazapine | 11 | $56 | $5 |
| Warfarin | 15 | $48 | $3 |
| Diazepam | 23 | $45 | $2 |
| Furosemide | 12 | $37 | $3 |
| Meloxicam | 13 | $29 | $2 |
Year by year
| 2024 | 2,075 | 370 | 13% (260) | None | $3,437,685 |
| 2023 | 1,925 | 317 | 13% (249) | 14% | $2,618,446 |
| 2022 | 1,666 | 288 | 10% (165) | None | $3,131,803 |
| 2021 | 1,242 | 210 | 12% (151) | 22% | $2,175,600 |
| 2020 | 1,155 | 168 | 11% (121) | 22% | $2,440,736 |
| 2019 | 797 | 159 | 13% (107) | 16% | $1,017,500 |
| 2018 | 427 | 102 | 13% (55) | 24% | $699,930 |
| 2017 | 1,469 | 155 | 3% (44) | None | $284,708 |
| 2016 | 1,782 | 107 | 2% (27) | 16% | $49,947 |
| 2015 | 293 | 87 | 15% (44) | 18% | $61,312 |
| 2014 | 257 | 73 | 21% (55) | None | $12,922 |
| 2013 | 149 | 48 | None | 12% | $9,689 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 54 drugs
| Revlimid | 30 | $545,414 | $18,180 |
| Imbruvica | 34 | $407,310 | $11,980 |
| Promacta | 12 | $188,069 | $15,672 |
| Venclexta | 34 | $186,888 | $5,497 |
| Erleada | 11 | $185,921 | $16,902 |
| Abiraterone Acetate | 78 | $183,748 | $2,356 |
| Ninlaro | 12 | $159,203 | $13,267 |
| Eliquis | 14 | $12,309 | $879 |
| Xtampza Er | 11 | $5,508 | $501 |
| Imatinib Mesylate | 14 | $3,061 | $219 |
| Anastrozole | 106 | $3,015 | $28 |
| Fentanyl | 12 | $2,164 | $180 |
| Hydrocodone-Acetaminophen | 69 | $1,958 | $28 |
| Hydroxyurea | 34 | $1,905 | $56 |
| Exemestane | 21 | $1,681 | $80 |
| Oxycodone-Acetaminophen | 44 | $1,501 | $34 |
| Dexamethasone | 76 | $1,371 | $18 |
| Morphine Sulfate Er | 38 | $1,218 | $32 |
| Gabapentin | 66 | $1,093 | $17 |
| Bicalutamide | 29 | $1,020 | $35 |
| Prednisone | 96 | $816 | $8 |
| Zolpidem | 30 | $686 | $23 |
| Levothyroxine | 57 | $603 | $11 |
| Ondansetron | 67 | $563 | $8 |
| Albuterol Sulfate Hfa | 14 | $540 | $39 |
| Tamsulosin | 23 | $540 | $23 |
| Potassium Chloride | 35 | $491 | $14 |
| Oxycodone | 32 | $488 | $15 |
| Escitalopram | 19 | $488 | $26 |
| Letrozole | 21 | $467 | $22 |
| Fluticasone Propionate | 12 | $464 | $39 |
| Metoprolol | 21 | $431 | $21 |
| Lorazepam | 37 | $404 | $11 |
| Tamoxifen Citrate | 18 | $395 | $22 |
| Ondansetron Odt | 13 | $351 | $27 |
| Losartan | 13 | $338 | $26 |
| Celecoxib | 12 | $293 | $24 |
| Acetaminophen-Codeine | 17 | $290 | $17 |
| Duloxetine | 12 | $242 | $20 |
| Clotrimazole-Betamethasone | 12 | $241 | $20 |
| Prochlorperazine Maleate | 16 | $225 | $14 |
| Alprazolam | 33 | $218 | $7 |
| Acyclovir | 13 | $207 | $16 |
| Methylprednisolone | 19 | $205 | $11 |
| Fluconazole | 11 | $198 | $18 |
| Promethazine | 16 | $164 | $10 |
| Tramadol | 19 | $150 | $8 |
| Lansoprazole | 12 | $149 | $12 |
| Lidocaine Hcl Viscous | 14 | $145 | $10 |
| Levofloxacin | 22 | $142 | $6 |
| Pantoprazole | 12 | $138 | $11 |
| Diazepam | 19 | $65 | $3 |
| Clonazepam | 13 | $45 | $3 |
| Furosemide | 19 | $43 | $2 |
2022: 43 drugs
| Revlimid | 50 | $899,403 | $17,988 |
| Imbruvica | 76 | $756,903 | $9,959 |
| Lonsurf | 19 | $173,636 | $9,139 |
| Venclexta | 16 | $88,870 | $5,554 |
| Promacta | 14 | $84,414 | $6,030 |
| Deferiprone | 11 | $36,540 | $3,322 |
| Abiraterone Acetate | 13 | $22,183 | $1,706 |
| Imatinib Mesylate | 19 | $18,864 | $993 |
| Eliquis | 13 | $10,949 | $842 |
| Exemestane | 21 | $3,438 | $164 |
| Anastrozole | 94 | $2,097 | $22 |
| Lansoprazole | 13 | $1,521 | $117 |
| Oxycodone-Acetaminophen | 29 | $1,465 | $51 |
| Hydrocodone-Acetaminophen | 50 | $1,366 | $27 |
| Dexamethasone | 67 | $1,230 | $18 |
| Hydroxyurea | 32 | $1,192 | $37 |
| Ondansetron | 76 | $1,144 | $15 |
| Bicalutamide | 33 | $1,093 | $33 |
| Gabapentin | 80 | $880 | $11 |
| Nitrofurantoin Mono-Macro | 15 | $709 | $47 |
| Levothyroxine | 47 | $663 | $14 |
| Triamcinolone Acetonide | 13 | $630 | $48 |
| Morphine Sulfate Er | 19 | $604 | $32 |
| Zolpidem | 31 | $600 | $19 |
| Potassium Chloride | 32 | $559 | $17 |
| Prochlorperazine Maleate | 23 | $545 | $24 |
| Diphenoxylate-Atropine | 18 | $485 | $27 |
| Prednisone | 45 | $407 | $9 |
| Oxycodone | 29 | $373 | $13 |
| Lorazepam | 33 | $369 | $11 |
| Escitalopram | 23 | $341 | $15 |
| Ondansetron Odt | 13 | $318 | $24 |
| Letrozole | 12 | $296 | $25 |
| Diltiazem 24hr Er (Cd) | 13 | $254 | $20 |
| Metoprolol | 21 | $253 | $12 |
| Amlodipine Besylate | 18 | $161 | $9 |
| Alprazolam | 28 | $118 | $4 |
| Tamoxifen Citrate | 17 | $96 | $6 |
| Losartan | 18 | $83 | $5 |
| Azithromycin | 13 | $73 | $6 |
| Diazepam | 14 | $60 | $4 |
| Temazepam | 11 | $59 | $5 |
| Amoxicillin | 12 | $32 | $3 |
2021: 38 drugs
| Revlimid | 36 | $651,157 | $18,088 |
| Imbruvica | 73 | $547,849 | $7,505 |
| Cabometyx | 17 | $206,612 | $12,154 |
| Ninlaro | 15 | $188,606 | $12,574 |
| Jakafi | 11 | $171,623 | $15,602 |
| Imatinib Mesylate | 19 | $46,371 | $2,441 |
| Eliquis | 26 | $13,707 | $527 |
| Oxycodone-Acetaminophen | 57 | $2,712 | $48 |
| Anastrozole | 51 | $1,600 | $31 |
| Exemestane | 12 | $1,396 | $116 |
| Gabapentin | 52 | $1,139 | $22 |
| Bicalutamide | 11 | $1,053 | $96 |
| Hydroxyurea | 25 | $823 | $33 |
| Dexamethasone | 36 | $724 | $20 |
| Hydrocodone-Acetaminophen | 30 | $609 | $20 |
| Potassium Chloride | 38 | $579 | $15 |
| Bumetanide | 14 | $560 | $40 |
| Oxycodone | 20 | $524 | $26 |
| Ondansetron | 47 | $507 | $11 |
| Levothyroxine | 32 | $494 | $15 |
| Letrozole | 15 | $463 | $31 |
| Prednisone | 44 | $400 | $9 |
| Morphine Sulfate Er | 12 | $304 | $25 |
| Prochlorperazine Maleate | 12 | $253 | $21 |
| Pantoprazole | 18 | $236 | $13 |
| Lisinopril | 18 | $230 | $13 |
| Metoprolol | 11 | $212 | $19 |
| Tramadol | 17 | $192 | $11 |
| Azithromycin | 12 | $148 | $12 |
| Tamsulosin | 14 | $146 | $10 |
| Amlodipine Besylate | 16 | $142 | $9 |
| Alprazolam | 28 | $120 | $4 |
| Euthyrox | 13 | $118 | $9 |
| Temazepam | 17 | $117 | $7 |
| Lorazepam | 20 | $113 | $6 |
| Pramipexole Dihydrochloride | 12 | $112 | $9 |
| Furosemide | 20 | $96 | $5 |
| Meloxicam | 12 | $63 | $5 |
2020: 37 drugs
| Revlimid | 37 | $641,620 | $17,341 |
| Imbruvica | 60 | $606,556 | $10,109 |
| Xtandi | 23 | $229,646 | $9,985 |
| Jakafi | 14 | $204,907 | $14,636 |
| Sprycel | 11 | $168,530 | $15,321 |
| Ninlaro | 14 | $157,156 | $11,225 |
| Promacta | 12 | $89,681 | $7,473 |
| Imatinib Mesylate | 30 | $77,318 | $2,577 |
| Eliquis | 12 | $6,759 | $563 |
| Xarelto | 11 | $5,277 | $480 |
| Anastrozole | 57 | $1,480 | $26 |
| Ondansetron | 79 | $1,365 | $17 |
| Tamoxifen Citrate | 13 | $973 | $75 |
| Potassium Chloride | 34 | $939 | $28 |
| Hydroxyurea | 29 | $834 | $29 |
| Fentanyl | 11 | $829 | $75 |
| Hydrocodone-Acetaminophen | 42 | $813 | $19 |
| Gabapentin | 49 | $732 | $15 |
| Oxycodone-Acetaminophen | 17 | $608 | $36 |
| Levothyroxine | 30 | $600 | $20 |
| Mirtazapine | 11 | $508 | $46 |
| Letrozole | 14 | $358 | $26 |
| Zolpidem | 15 | $349 | $23 |
| Dexamethasone | 29 | $245 | $8 |
| Hydromorphone | 18 | $225 | $12 |
| Temazepam | 21 | $203 | $10 |
| Bicalutamide | 12 | $197 | $16 |
| Lorazepam | 23 | $172 | $7 |
| Prednisone | 25 | $162 | $6 |
| Baclofen | 12 | $139 | $12 |
| Tramadol | 18 | $113 | $6 |
| Furosemide | 14 | $96 | $7 |
| Alprazolam | 21 | $94 | $4 |
| Meloxicam | 21 | $79 | $4 |
| Amlodipine Besylate | 16 | $75 | $5 |
| Pantoprazole | 13 | $70 | $5 |
| Diazepam | 13 | $55 | $4 |
2019: 21 drugs
| Revlimid | 20 | $310,394 | $15,520 |
| Xtandi | 22 | $261,044 | $11,866 |
| Imatinib Mesylate | 19 | $136,678 | $7,194 |
| Eliquis | 14 | $6,716 | $480 |
| Tamoxifen Citrate | 27 | $1,598 | $59 |
| Anastrozole | 52 | $1,462 | $28 |
| Oxycodone-Acetaminophen | 35 | $1,082 | $31 |
| Gabapentin | 34 | $796 | $23 |
| Hydrocodone-Acetaminophen | 40 | $777 | $19 |
| Ondansetron | 54 | $773 | $14 |
| Potassium Chloride | 20 | $666 | $33 |
| Dexamethasone | 27 | $584 | $22 |
| Levothyroxine | 18 | $543 | $30 |
| Hydroxyurea | 18 | $527 | $29 |
| Bicalutamide | 11 | $234 | $21 |
| Temazepam | 17 | $222 | $13 |
| Lorazepam | 17 | $149 | $9 |
| Acyclovir | 14 | $136 | $10 |
| Meloxicam | 31 | $87 | $3 |
| Prednisone | 18 | $75 | $4 |
| Furosemide | 21 | $49 | $2 |
2018: 12 drugs
| Revlimid | 15 | $270,616 | $18,041 |
| Ninlaro | 13 | $127,375 | $9,798 |
| Xtandi | 11 | $119,560 | $10,869 |
| Eliquis | 11 | $5,042 | $458 |
| Tamoxifen Citrate | 13 | $1,320 | $102 |
| Anastrozole | 44 | $664 | $15 |
| Ondansetron | 18 | $195 | $11 |
| Letrozole | 11 | $149 | $14 |
| Hydrocodone-Acetaminophen | 12 | $118 | $10 |
| Dexamethasone | 11 | $97 | $9 |
| Levothyroxine | 12 | $88 | $7 |
| Meloxicam | 18 | $53 | $3 |
2017: 40 drugs
| Lantus | 24 | $8,134 | $339 |
| Xarelto | 15 | $2,573 | $172 |
| Januvia | 12 | $2,256 | $188 |
| Tamoxifen Citrate | 17 | $1,200 | $71 |
| Hydroxyurea | 18 | $891 | $50 |
| Oxycodone-Acetaminophen | 12 | $569 | $47 |
| Gabapentin | 70 | $567 | $8 |
| Anastrozole | 26 | $411 | $16 |
| Potassium Chloride | 26 | $407 | $16 |
| Levothyroxine | 52 | $396 | $8 |
| Metoprolol | 33 | $363 | $11 |
| Famotidine | 70 | $356 | $5 |
| Ondansetron | 20 | $325 | $16 |
| Atorvastatin | 47 | $318 | $7 |
| Oxybutynin Chloride | 15 | $307 | $20 |
| Ipratropium-Albuterol | 14 | $280 | $20 |
| Lisinopril | 55 | $255 | $5 |
| Divalproex | 16 | $244 | $15 |
| Tamsulosin | 20 | $222 | $11 |
| Klor-Con 10 | 15 | $184 | $12 |
| Amlodipine Besylate | 45 | $183 | $4 |
| Clopidogrel | 33 | $174 | $5 |
| Furosemide | 41 | $163 | $4 |
| Glimepiride | 17 | $135 | $8 |
| Citalopram Hbr | 22 | $123 | $6 |
| Enalapril Maleate | 11 | $122 | $11 |
| Isosorbide Mononitrate Er | 16 | $118 | $7 |
| Acetaminophen-Codeine | 11 | $117 | $11 |
| Dexamethasone | 13 | $111 | $9 |
| Prednisone | 21 | $106 | $5 |
| Hydrochlorothiazide | 26 | $105 | $4 |
| Escitalopram | 16 | $103 | $6 |
| Olanzapine | 11 | $102 | $9 |
| Sertraline | 18 | $97 | $5 |
| Omeprazole | 15 | $93 | $6 |
| Metformin | 24 | $88 | $4 |
| Spironolactone | 13 | $79 | $6 |
| Metoprolol | 16 | $67 | $4 |
| Atenolol | 11 | $55 | $5 |
| Meloxicam | 13 | $40 | $3 |
2016: 42 drugs
| Januvia | 24 | $4,246 | $177 |
| Xarelto | 19 | $3,382 | $178 |
| Potassium Chloride | 92 | $1,130 | $12 |
| Divalproex | 32 | $817 | $26 |
| Gabapentin | 75 | $708 | $9 |
| Galantamine Er | 11 | $697 | $63 |
| Esomeprazole Magnesium | 11 | $643 | $58 |
| Levothyroxine | 69 | $630 | $9 |
| Metoprolol | 48 | $473 | $10 |
| Atorvastatin | 75 | $472 | $6 |
| Lisinopril | 97 | $431 | $4 |
| Famotidine | 52 | $369 | $7 |
| Amlodipine Besylate | 83 | $364 | $4 |
| Omeprazole | 50 | $324 | $6 |
| Citalopram Hbr | 53 | $305 | $6 |
| Clopidogrel | 55 | $290 | $5 |
| Tamsulosin | 32 | $275 | $9 |
| Isosorbide Mononitrate Er | 35 | $245 | $7 |
| Furosemide | 48 | $238 | $5 |
| Klor-Con 10 | 22 | $206 | $9 |
| Metformin | 43 | $190 | $4 |
| Baclofen | 19 | $185 | $10 |
| Escitalopram | 27 | $184 | $7 |
| Oxybutynin Chloride | 12 | $169 | $14 |
| Carbidopa-Levodopa | 16 | $169 | $11 |
| Latanoprost | 14 | $159 | $11 |
| Quetiapine | 17 | $158 | $9 |
| Sertraline | 31 | $153 | $5 |
| Paroxetine | 24 | $151 | $6 |
| Hydrochlorothiazide | 34 | $137 | $4 |
| Metoprolol | 26 | $135 | $5 |
| Pantoprazole | 15 | $129 | $9 |
| Glimepiride | 27 | $128 | $5 |
| Valsartan | 12 | $124 | $10 |
| Olanzapine | 13 | $106 | $8 |
| Enalapril Maleate | 11 | $99 | $9 |
| Carvedilol | 15 | $99 | $7 |
| Mirtazapine | 11 | $92 | $8 |
| Losartan | 18 | $88 | $5 |
| Clonidine | 13 | $76 | $6 |
| Atenolol | 14 | $67 | $5 |
| Terazosin | 11 | $62 | $6 |
2015: 5 drugs
| Hydrocodone-Acetaminophen | 20 | $605 | $30 |
| Potassium Chloride | 26 | $442 | $17 |
| Famotidine | 18 | $107 | $6 |
| Amlodipine Besylate | 17 | $95 | $6 |
| Lisinopril | 16 | $59 | $4 |
2014: 6 drugs
| Hydrocodone-Acetaminophen | 24 | $540 | $22 |
| Potassium Chloride | 19 | $452 | $24 |
| Divalproex | 14 | $100 | $7 |
| Hydrochlorothiazide | 19 | $79 | $4 |
| Metformin | 12 | $69 | $6 |
| Lisinopril | 19 | $68 | $4 |
2013: 3 drugs
| Anastrozole | 12 | $302 | $25 |
| Alendronate | 11 | $180 | $16 |
| Metformin | 14 | $149 | $11 |
Money from drug and device companies
$221 in 2025
| 2025 | 1 | 5 | None | $221 |
| 2024 | 2 | 2 | None | $49 |
| 2023 | 3 | 4 | None | $100 |
| 2022 | 2 | 3 | None | $58 |
| 2021 | 2 | 5 | None | $84 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tempus AI | Xt Cdx | $221 | 5 payments
|
See all 5 published payments
| Tempus AI | Meals · 2025-12-18 | Xt Cdx | $54 |
| Tempus AI | Meals · 2025-11-09 | Xt Cdx | $27 |
| Tempus AI | Meals · 2025-10-06 | Xt Cdx | $28 |
| Tempus AI | Meals · 2025-08-05 | Xt Cdx | $69 |
| Tempus AI | Meals · 2025-07-31 | Xt Cdx | $44 |
See earlier years (2024, 2023, 2022, 2021)
2024: $49
| Novartis Pharmaceuticals | Pluvicto | $32 | 1 payment
|
| Tempus AI | Xt Cdx | $18 | 1 payment
|
2023: $100
| Myriad Genetic Laboratories | Myrisk | $50 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $29 | 1 payment
|
| GlaxoSmithKline | Shingrix | $21 | 1 payment
|
2022: $58
| Eisai | Lenvima | $44 | 2 payments
|
| Myovant Sciences | Orgovyx | $14 | 1 payment
|
2021: $84
| Pfizer | Ibrance | $44 | 2 payments
|
| Acrotech Biopharma | Beleodaq | $40 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 79.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1962482877
- Licence
- CA PA17521
- Trained
- University of California, Davis School of Medicine, 2004 · 22 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA OPA175210
- Taxonomy
- Physician assistant (363A00000X); Medical oncology (207RX0202X); Federal specialty code 364SE0003X (364SE0003X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-01-18
- NPI last updated
- 2025-02-07
- NPI record certified
- 2025-02-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1000 Greenley Rd, Sonora, CA, 95370